We are pleased to share our publication describing the invention, development, optimization, and validation of the Detecting Early Neuropathy to Treat Early Neuropatht (DEN-TEN) theragnostic device, that is patent pending. Here we demonstrated that DEN-TEN and associated FOX-DEN software could accurately detect neuropathy in a diet-induced pre-clinical model. Then we moved to a flexible array for human testing, which we are now utilizing in a clinical trial with Ohio State. Thank you to our wonderful colleagues and collaborators! https://lnkd.in/gQE793kN
Neuright, Inc.
生物技术研究
Columbus，OH 85 位关注者
Neuright, Inc., an academic spin-out, is developing new diagnostic and therapeutic options for peripheral neuropathy.
关于我们
Neuright, Inc. is a biotech start-up comprised of a team of neurobiologists and biomedical engineers. Neuright was founded in Maine in 2018 as a C-corp and Now has offices in Orono Maine and Columbus Ohio. Neuright is now transitioning their MVP diagnostic device for peripheral neuropathy to first in human testing, in partnership with doctors at The Ohio State University.
- 网站
-
https://neurightlabs.com
Neuright, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Columbus，OH
- 类型
- 私人持股
- 创立
- 2018
- 领域
- diagnostic、theragnostic、therapeutic、biomedical和healthcare